Activation of FGFR-signaling mediates resistance of gastrointestinal stromal tumors (GISTs) to imatinib (IM)

被引：0
作者：
Garanina, E. [1 ]
Boichuk, S. [2 ]
Dunaev, P. [2 ]
Galembikova, A. [2 ]
Shagimardanova, E. [1 ]
Gusev, O. [1 ]
Khaiboullina, S. [1 ]
机构：
[1] Kazan Fed Univ, Kazan, Russia
[2] Kazan State Med Univ, Kazan, Russia
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 48卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P071-F
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [11] Gastrointestinal stromal tumors (GISTs)
    Saund, MS
    Demetri, GD
    Ashley, SW
    CURRENT OPINION IN GASTROENTEROLOGY, 2004, 20 (02) : 89 - 94
  • [12] KIT mutations and sunitinib resistance in gastrointestinal stromal tumors (GISTs)
    Fletcher, J. A.
    Corless, C. L.
    Liegl, B.
    Fletcher, C. D.
    Raut, C. P.
    Donsky, R.
    Bertagnolli, M. M.
    Harlow, A.
    Demetri, G. D.
    Heinrich, M. C.
    EJC SUPPLEMENTS, 2007, 5 (04): : 403 - 403
  • [13] Molecular correlates ofsunitinib resistance in gastrointestinal stromal tumors (GISTS)
    Fletcher, J.
    Corless, C.
    Liegl, B.
    Fletcher, C.
    Raut, C.
    Donsky, R.
    Bertagnolli, M.
    Hadow, A.
    Demetri, G.
    Heinrich, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII15 - VII16
  • [14] GASTROINTESTINAL STROMAL TUMOURS (GISTS) AND LATE RESISTANCE TO IMATINIB MESYLATE (IM): MIGHT HIGHER DOSES HAVE A ROLE IN OVERCOMING RESISTANCE?
    Ciccarese, M.
    Ferraresi, V.
    Gelibter, A.
    Zeuli, M.
    Cognetti, F.
    ANNALS OF ONCOLOGY, 2004, 15 : 73 - 74
  • [15] FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors
    Li, Fang
    Huynh, Hung
    Li, Xiaoyan
    Ruddy, David A.
    Wang, Youzhen
    Ong, Richard
    Chow, Pierce
    Qiu, Shumei
    Tam, Angela
    Rakiec, Daniel P.
    Schlegel, Robert
    Monahan, John E.
    Huang, Alan
    CANCER DISCOVERY, 2015, 5 (04) : 438 - 451
  • [16] Gastrointestinal stromal tumors (GISTs): a review
    Steigen, Sonja E.
    Eide, Tor J.
    APMIS, 2009, 117 (02) : 73 - 86
  • [17] Gastrointestinal stromal tumors (GISTs) of the colon
    Macias Garcia, F.
    Parada, P.
    Martinez-Lesquereux, L.
    Pintos, E.
    Fraga, M.
    Dominguez Munoz, J. E.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2010, 102 (06) : 388 - 390
  • [18] Imatinib Dosing in Gastrointestinal Stromal Tumors (GISTs): When, How Much, and How Long?
    Milhem, Mohammed
    Deutsch, Jeremy M.
    CURRENT CLINICAL PHARMACOLOGY, 2015, 10 (04): : 311 - 320
  • [19] Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs)
    Sym, Sun Jin
    Ryu, Min-Hee
    Lee, Jae-Lyun
    Chang, Heung Moon
    Kim, Tae-Won
    Kim, Hee Cheol
    Kim, Ki Hun
    Yook, Jeong Hwan
    Kim, Byung Sik
    Kang, Yoon-Koo
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (01) : 27 - 33
  • [20] Molecular correlates of imatinib resistance in gastrointestinal stromal tumors
    Heinrich, Michael C.
    Corless, Christopher L.
    Blanke, Charles D.
    Demetri, George D.
    Joensuu, Heikki
    Roberts, Peter J.
    Eisenberg, Burton L.
    von Mehren, Margaret
    Fletcher, Christopher D. M.
    Sandau, Katrin
    McDougall, Karen
    Ou, Wen-bin
    Chen, Chang-Jie
    Fletcher, Jonathan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (29) : 4764 - 4774
12345